• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[评估心血管疾病预防措施效果所需人群组规模的计算(以考纳斯调查为例)]

[Calculation of the size of the population group necessary for evaluation of the results of measures for the prevention of cardiovascular diseases (on the example of the Kaunas survey)].

作者信息

Daud D E, Glazunov I S, Ianushkevichus Z I

出版信息

Kardiologiia. 1977 Aug;17(8):10-6.

PMID:926549
Abstract

A method for estimating the size of the group necessary in evaluation of the efficacy of preventive intervention among the population is described. The parameters for calculating the necessary size of the sample from an equation and the fundamentals of compiling tables by means of electronic computers are discussed. The data of the Kaunas survey conducted according to the WHO program illustrate the statistical approach. The material of the Kaunas survey is also used to estimate the size of the population necessary for testing the hypothesis on the possibility of preventing myocardial infarction by reducing the risk factor.

摘要

本文描述了一种估算在人群中评估预防性干预效果所需样本量的方法。讨论了从一个方程计算所需样本量的参数以及借助电子计算机编制表格的基本原理。根据世界卫生组织计划进行的考纳斯调查数据说明了这种统计方法。考纳斯调查的材料还用于估算为检验通过降低危险因素预防心肌梗死可能性的假设所需的人群规模。

相似文献

1
[Calculation of the size of the population group necessary for evaluation of the results of measures for the prevention of cardiovascular diseases (on the example of the Kaunas survey)].[评估心血管疾病预防措施效果所需人群组规模的计算(以考纳斯调查为例)]
Kardiologiia. 1977 Aug;17(8):10-6.
2
[Prevention of cardiovascular disease in the elderly].
Presse Med. 2000 Jun 24;29(22):1234-9.
3
[Participation of the population in mass screening and the role of complete population surveillance for detection of the disease studied (from the experience of the methodical measures for the prevention of ischemic heart disease in Kaunas)].[人群参与大规模筛查及全人群监测在所研究疾病检测中的作用(来自考纳斯预防缺血性心脏病方法性措施的经验)]
Kardiologiia. 1977 Aug;17(8):16-20.
4
Mortality and morbidity indicators of acute myocardial infarction in participants and non-participants in population studies conducted in Moscow and Kaunas.在莫斯科和考纳斯开展的人群研究中,参与者与非参与者急性心肌梗死的死亡率和发病率指标。
Cor Vasa. 1989;31(4):264-71.
5
[Multifactorial prophylaxis of ischemic heart disease (a cooperative study)].[缺血性心脏病的多因素预防(一项合作研究)]
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR. 1983;6(1):43-8.
6
[Secondary prevention of arterial hypertension in an organized population: methods of implementation, efficacy, prospects].[有组织人群中动脉高血压的二级预防:实施方法、疗效及前景]
Kardiologiia. 1987 Jan;27(1):69-74.
7
[Prospective epidemiologic study of arterial hypertension in an organized male population].
Kardiologiia. 1987 Jan;27(1):74-7.
8
[Experience in conducting a multifactor ischemic heart disease prevention program (data from a cooperative study in Moscow and Kaunas].开展多因素缺血性心脏病预防项目的经验(来自莫斯科和考纳斯合作研究的数据)
Kardiologiia. 1980 Jul;20(7):31-5.
9
[Heart and brain: are the risk factors the same? Are the results of primary and secondary trials comparable?].
Arch Mal Coeur Vaiss. 1998 Oct;91 Spec No 5:59-63.
10
[Intervention in risk factors and protection of target organs].
An Med Interna. 1997 Sep;14(9):478-84.